Á lódáil...
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
Na minha lista:
| Príomhúdar: | |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe: |
IMA-PRESS LLC
2009-12-01
|
| Sraith: | Современная ревматология |
| Ábhair: | |
| Rochtain Ar Líne: | https://mrj.ima-press.net/mrj/article/view/261 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|